{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:50:57Z","timestamp":1782316257093,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.prp.2023.154919","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T23:23:35Z","timestamp":1699053815000},"page":"154919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"252","author":[{"given":"Yong-qiang","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-5399","authenticated-orcid":false,"given":"Yong-jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.prp.2023.154919_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.prp.2023.154919_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101148","article-title":"Analysis of the impact of fatty acid metabolism on immunotherapy for hepatocellular carcinoma","volume":"28","author":"Wang","year":"2023","journal-title":"Ann. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"23","key":"10.1016\/j.prp.2023.154919_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201703","article-title":"Polypyrrole nanoenzymes as tumor microenvironment modulators to reprogram macrophage and potentiate immunotherapy","volume":"9","author":"Zeng","year":"2022","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.prp.2023.154919_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.prp.2023.154919_bib7","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.prp.2023.154919_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002636","article-title":"High infiltration of tumor-associated macrophages influences poor prognosis in human gastric cancer patients, associates with the phenomenon of EMT","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.prp.2023.154919_bib9","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1245\/s10434-011-1609-3","article-title":"Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection","volume":"18","author":"Wang","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154919_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.prp.2023.154919_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.prp.2023.154919_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.prp.2023.154919_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.prp.2023.154919_bib14","doi-asserted-by":"crossref","first-page":"1132177","DOI":"10.3389\/fonc.2023.1132177","article-title":"Influence of statin use on prognosis of patients with renal cell cancer: a meta-analysis","volume":"13","author":"Liang","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2023.154919_bib15","doi-asserted-by":"crossref","first-page":"1211171","DOI":"10.3389\/fimmu.2023.1211171","article-title":"Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059771","article-title":"The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma","volume":"8","author":"Kong","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.prp.2023.154919_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jcmm.12787","article-title":"Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection","volume":"20","author":"Shu","year":"2016","journal-title":"J. Cell Mol. Med"},{"issue":"4","key":"10.1016\/j.prp.2023.154919_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1309\/AJCP86PPBNGOHNNL","article-title":"Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection","volume":"131","author":"Ju","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"issue":"39","key":"10.1016\/j.prp.2023.154919_bib19","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.3748\/wjg.v22.i39.8779","article-title":"Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma","volume":"22","author":"Kono","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3892\/or.2017.5738","article-title":"Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value","volume":"38","author":"Ren","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s12885-016-2883-z","article-title":"High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12967-017-1139-2","article-title":"Distinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer","volume":"15","author":"Li","year":"2017","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/ijms17030320","article-title":"CD86(+)\/CD206(+), diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis","volume":"17","author":"Dong","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2023.154919_bib24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/liv.12466","article-title":"Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma","volume":"34","author":"Ohno","year":"2014","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","article-title":"Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma","volume":"62","author":"Yeung","year":"2015","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.4720","article-title":"CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma","volume":"239","author":"Zhang","year":"2016","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2019.04.007","article-title":"Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma","volume":"71","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib28","first-page":"3218","article-title":"Identification of CD206 as a potential biomarker of cancer stem-like cells and therapeutic agent in liver cancer","volume":"18","author":"Fan","year":"2019","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.prp.2023.154919_bib29","first-page":"4805","article-title":"The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and \u03b1-SMA","volume":"15","author":"Fang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00262-020-02685-7","article-title":"Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma","volume":"70","author":"Hu","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.prp.2023.154919_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109523","article-title":"MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis","volume":"120","author":"Ke","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ymthe.2021.09.021","article-title":"Type I IFNs repolarized a CD169(+) macrophage population with anti-tumor potentials in hepatocellular carcinoma","volume":"30","author":"Liao","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3233\/CBM-203003","article-title":"Prognostic and predictive significance of the tumor microenvironment in hepatocellular carcinoma","volume":"32","author":"Liu","year":"2021","journal-title":"Cancer Biomark."},{"issue":"5","key":"10.1016\/j.prp.2023.154919_bib34","first-page":"4465","article-title":"Prognostic significance of CD68, CD163 and Folate receptor-\u03b2 positive macrophages in hepatocellular carcinoma","volume":"15","author":"Minami","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/cas.15202","article-title":"The spatial distribution of immune cell subpopulations in hepatocellular carcinoma","volume":"113","author":"Wang","year":"2022","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.prp.2023.154919_bib36","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1111\/cas.15437","article-title":"Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma","volume":"113","author":"Yusa","year":"2022","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.prp.2023.154919_bib37","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3892\/or.2015.4268","article-title":"GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor\u2011associated macrophages","volume":"34","author":"Zhu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"16","key":"10.1016\/j.prp.2023.154919_bib38","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1200\/JCO.2007.15.6521","article-title":"High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma","volume":"26","author":"Zhu","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ijc.23966","article-title":"Frequent expression of the novel cancer testis antigen MAGE-C2\/CT-10 in hepatocellular carcinoma","volume":"124","author":"Riener","year":"2009","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib40","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2010.207","article-title":"Fibrolamellar carcinomas are positive for CD68","volume":"24","author":"Ross","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154919_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-981-10-6020-5_16","article-title":"Tumor associated macrophages as therapeutic targets for breast cancer","volume":"1026","author":"Lao","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.prp.2023.154919_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humpath.2017.12.010","article-title":"Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer","volume":"74","author":"Ojalvo","year":"2018","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154919_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.urolonc.2017.11.020","article-title":"M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer","volume":"36","author":"Aljabery","year":"2018","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2023.154919_bib44","article-title":"Tumor immunophenotyping-derived signature identifies prognosis and neoadjuvant immunotherapeutic responsiveness in gastric cancer","author":"Wang","year":"2023","journal-title":"Adv. Sci."},{"issue":"670","key":"10.1016\/j.prp.2023.154919_bib45","doi-asserted-by":"crossref","first-page":"eabo4997","DOI":"10.1126\/scitranslmed.abo4997","article-title":"Advancing beyond the twists and turns of T cell exhaustion in cancer","volume":"14","author":"van der Heide","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib46","first-page":"5","article-title":"Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines","volume":"71","author":"Mantovani","year":"1994","journal-title":"Lab Invest."},{"issue":"8","key":"10.1016\/j.prp.2023.154919_bib47","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2023.154919_bib48","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/j.gastro.2021.12.273","article-title":"Loss of Rnf43 accelerates kras-mediated neoplasia and remodels the tumor immune microenvironment in pancreatic adenocarcinoma","volume":"162","author":"Hosein","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prp.2023.154919_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.prp.2023.154919_bib52","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1189\/jlb.0907611","article-title":"Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes\/macrophages that bear M1- and M2-type characteristics","volume":"83","author":"Umemura","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"24","key":"10.1016\/j.prp.2023.154919_bib53","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1158\/0008-5472.CAN-08-0911","article-title":"Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients","volume":"68","author":"Sakai","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2017.07.007","article-title":"Prognostic significance of tumor-associated macrophages in ovarian cancer: a meta-analysis","volume":"147","author":"Yuan","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2023.154919_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079769","article-title":"High MUC2 expression in ovarian cancer is inversely associated with the M1\/M2 ratio of tumor-associated macrophages and patient survival time","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib56","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1038\/s41598-017-08128-1","article-title":"The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"7","author":"Yao","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00432-008-0469-0","article-title":"Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection","volume":"135","author":"Li","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2023.154919_bib58","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2009.07.013","article-title":"Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients","volume":"52","author":"Chew","year":"2010","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.23291","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells","volume":"51","author":"Kuang","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.prp.2023.154919_bib60","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1245\/s10434-013-3445-0","article-title":"Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154919_bib61","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12885-023-11027-6","article-title":"Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:01:09Z","timestamp":1759734069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823006209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":61,"alternative-id":["S0344033823006209"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154919","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The correlation between tumor-associated macrophages and the prognosis of east Asian hepatocellular carcinoma patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154919"}}